CEO Richard Francis reflects on Teva’s return to growth during his tenure,
and what’s next for the drugmaker in its quest to recapture the heights of old.
Veeva’s vice president of commercial strategy discusses how pharma companies streamlining their processes with a single goal in mind can improve their relationships with customers.
While challenges remain, AI is accelerating the process by enabling researchers to identify and design new drug candidates more quickly and efficiently with applications in target discovery, structure prediction, and drug optimization.